Four anti-bisphenol A monoclonal antibodies (mabs) were obtained and each characterized by an enzymelinked immunosorbent assay (ELISA). Among these mabs, BBA-2187 was the most reactive towards bisphenol A. The quantitation limit of the ELISA assay for bisphenol A was 0.13 ng W ml, which is more sensitive than the other immunoassays reported. Then, the cDNA clones encoding variable heavy and variable light chains of these four mabs were isolated, and used for construction of four single-chain Fv (scFv) antibody genes, which were expressed in Escherichia coli cells. The reactivity of four scFv antibodies towards bisphenol A in ELISA was comparable to those of the parent mabs. The most sensitive assay was achieved with BBA-2187scFv. Its cross-reactivity to the related compounds was similar to that of the parent mab. Based on the reactivity of heterologous combinations of VH and VL fragments, it was found that the unique structure of the framework region 2 in the VL of BBA-2187 appeared to be important for speciˆc assembly together with the VH.
Expansion of contamination of the environment and agricultural products with persistent organic pollutants (POPs) is a serious global problem. These chemicals include dioxins, pesticide residues, and endocrine disruptors such as bisphenol A (BPA). This chemical is a monomer of polycarbonate plastics and a constituent of epoxy and polystyrene resins, which are extensively used as a plastic coating in the food packaging industry as well as in dentistry. 1) In Japan, the production of BPA was about 250,000 tons in 1996.
2) Krishnan 3) reported that BPA was released from ‰asks made of polycarbonate and had a weak estrogenic property. The binding a‹nity of the chemical towards the estrogen receptor in vitro was reported to be only 1 W 10,000 of the potency of 17 b-estradiol. 4) However, it was also reported that BPA can be leached from food and beverage containers into the food, 5) and leached from the can coating when canned products were heated at a high temperature. 6) In addition, BPA was found in saliva collected from patients who were treated with a BPA diglycidyl ether-based dental sealant. 7) Also, wastewater containing BPA from its production factories can be the source of contamination of aquatic environment. 1, 8) The Environmental Agency of Japan reported that contamination of the environment with BPA was widespread in Japan and the levels of BPA in freshwater and seawater samples ranged from ppt to ppb levels. 9) BPA also shows an acute toxicity in the range of about 1-10 mg W l towards algae, invertebrates, andˆsh. 10) Therefore, monitoring of contamination of the environment and food with BPA seems to be important for risk assessment of the chemical.
At present, gas chromatography-mass spectrometry (GC-MS), 11) high performance liquid chromatography (HPLC)-MS, 12) HPLC with ‰uorescence detection (HPLC-FLD), 13) and HPLC with electrochemical detection (HPLC-ECD) 14) are used for analysis of BPA. Although these methods are accurate and precise, these are labor-intensive and time-consuming. For rapid assessment of contamination of the environment and food with this chemical, development of a simple analytical method is very important. Enzyme-linked immunosorbent assay (ELISA) is handled readily and rapidly, and also deals with more samples than the instrumental analy- sis methods. Recently, many ELISA methods have been reported for POPs such as dioxins, 15, 16) polychlorinated biphenyls, 17, 18) and pesticide residues. [19] [20] [21] In this study, we attempted to prepare anti-BPA monoclonal antibodies (mabs) with high a‹nity and to develop a highly sensitive ELISA based on mabs. Furthermore, isolation of cDNA clones encoding anti-BPA mabs and expression of these cDNA clones in Escherichia coli were also attempted to produce recombinant antibodies. The molecular characteristics of these mabs and corresponding recombinant antibodies were assessed in ELISA. Fig. 1 ) was synthesized by Otsuka Chemical Co. (Tokushima, Japan). Bovine serum albumin (BSA) and rabbit serum albumin (RSA) were purchased from Sigma Chemical Co. (MO, USA). Keyhole limpet hemocyanin (KLH) and horseradish peroxidase (HRP)-conjugated anti-mouse IgG antibody were obtained from Pierce Chemical Co. (IL, USA). Block Ace was obtained from Dainippon Pharmaceutical Co. (Osaka, Japan). DNA polymerase was purchased from Roche Diagnostics GmbH (Mannheim, Germany). DNA restriction endonucleases were purchased from Takara Shuzo Co. (Shiga, Japan). All other chemicals and organic solvents were purchased from Nacalai Tesque, Inc. (Kyoto, Japan).
Materials and Methods
Preparation of hapten-protein conjugates. BPAH was covalently attached to a carrier protein by the active ester method. 22) BPAH (25 mmol) , N-hydroxysuccinimide (25 mmol) and N, N?-dicyclohexylcarbodiimide (25 mmol) were dissolved in 1.0 ml of dimethylformamide and the reaction mixture was stirred in the dark at room temperature overnight. The activated hapten solution was added dropwise to BSA (0.25 mmol), RSA (0.25 mmol), or KLH (0.25 mmol) in 0.1 M borate buŠer (pH 9.2) with stirring, and then the mixtures were stirred at room temperature overnight. Unconjugated BPAH was removed by dialysis against distilled water for 2 d at 49 C and the conjugates were lyophilized. The conjugates BPAH-BSA and BPAH-KLH were each used as an immunogen. BPAH-RSA was used as a coating antigen in ELISA.
Production of mabs. Five-week-old BALB W c female mice (Nippon SLC Co., Shizuoka, Japan) were immunized with 100 mg of BPAH-BSA or BPAH-KLH as an immunogen. Their splenocytes were fused with P3-X63-Ag8.653 myeloma cells 23) and screened for their binding ability towards BPA in ELISA as previously described.
24) The isotype of each of the mabs was identiˆed with anti-mouse subclass speciˆc antiserum (Bio-Rad Laboratories, CA, USA) according to the manufacturer's instructions.
Isolation of cDNA clones coding for anti-BPA variable regions by the 5?-rapid ampliˆcation of cDNA ends (RACE) method. Recombinant DNA techniques were according to the standard procedures. 25) Poly A ＋ RNA fractions were isolated from 2 ×10 7 cells of each of the hybridoma cell lines producing anti-BPA mabs using a QuickPrep Micro mRNA Puriˆcation Kit (Amersham Pharmacia Biotech, NJ, USA). Both the purity and amount of RNA were measured by UV spectrophotometry. To synthesize cDNA, 1 mg of a poly A ＋ RNA fraction was reverse transcribed using an oligo (dT) primer with MMLV reverse-transcriptase (Clontech, CA, USA). cDNA fragments encoding variable regions of anti-BPA antibodies were cloned by the 5?-RACE method using a SMART-RACE cDNA Ampliˆcation Kit (Clontech, CA, USA) with an universal primer mixture in the kit and gene-speciˆc primers (GSPs) for the constant regions of murine IgG1 heavy chain or k light chain. The GSP sequences were as follows; for the IgG1 chain 5?-GACAGATGGGGGTGTCGTTTTGGC-3?; for the k chain 5?-AGATGGATACAGTTGGT-GCAGCATCAGC-3?. The ampliˆed cDNA fragments were cloned into pT7Blue T-vector (Novagen, WI, USA) and used to transform E. coli JM109 cells. Colony PCR was used to screen positive clones, and plasmids of positive colonies were puriˆed and sequenced.
Nucleotide sequencing and analysis of nucleic acids. Recombinant plasmids were sequenced in an automated DNA sequencer SQ-5500 (Hitachi, Tokyo, Japan). DNA and deduced amino acid sequences were analyzed and aligned using the DNA sequence analysis software of Genetyx-Mac 7.3 (Software Development Co., Tokyo, Japan). The combination of the primers was used for construction of scFv, VH, and VL fragments as follow. BBA-2187scFv, H5-1, H3-1, L5-1 and L3-1; BBA2617scFv, H5-1, H3-1, L5-2 and L3-1; BKE-3430scFv, H5-2, H3-2, L5-3 and L3-2; BTE-3456scFv, H5-1, H3-1, L5-1 and L3-3; VL of BBA-2187, VL5-1 and VL3-1; VL of BBA-2617, VL5-2 and VL3-1; VL of BKE-3430, VL5-3 and VL3-2; VL of BTE-3456, VL5-1 and VL3-3; VH of BBA-2187, H5-1 and VH3-1; VH of BBA-2617, H5-1 and VH3-1; VH of BKE-3430, H5-2 and VH3-2; VH of BTE-3456, H5-1 and VH3-1. The plasmids for cDNAs encoding the VL fragments to be expressed in recombinant E. coli cells are represented. Abbreviations : T7 Pro, T7 promoter; pel B, pel B leader sequence; HSV tag, an epitope tag for detection with an anti-HSV mab; 6×His, a hexahistidine tag; FLAG tag, an epitope tag for detection with an anti-FLAG mab; T7 Ter, T7 terminator.
Construction of expression plasmids for antibody fragment genes. Four single-chain Fv (scFv) antibody genes were constructed by 2-step PCR as previously described. 26) Brie‰y, 10 primers were designed to construct scFv antibody genes based on nucleotide sequences of cDNA clones for the variable heavy chain (VH) and variable light chain (VL) of four anti-BPA mabs (Table 1) . The primers contained a ‰exi-ble peptide linker sequence encoding (Gly4Ser)3 to assemble VH and VL, or speciˆc sequences to facilitate the insertion of each of scFv genes into the NheI W NcoI site of the expression vector pET-27b (Novagen, WI, USA). VH cDNAs were ampliˆed with the H5-primers and H3-primers, and VL cDNAs were ampliˆed with the L5-primers and L3-primers in theˆrst PCR. Then VH and VL cDNAs were assembled in the second PCR with H5-primers and L3-primers. PCR products were ligated into pT7Blue Tvector and used to transform E. coli JM109 cells for DNA sequencing. Four scFv genes were digested with NheI W NcoI and ligated into the NheI W NcoI restricted vector pET-27b, which contained a pel B leader sequence 27) for periplasmic secretion of scFv antibody, a hexahistidine tag sequence, and an antiherpes simplex virus (HSV) tag for detection of scFv antibodies with a mouse anti-HSV mab (Novagen, WI, USA) in ELISA. The resulting expression plasmids (Fig. 2) were each used to transform E. coli BL21(DE3)pLysS strain cells.
Expression plasmids for VH and VL fragments of four mabs were also constructed by PCR. VH fragment genes were ampliˆed with H5-primers and VH3-primers, and VL fragment genes were with VL5-primers and VL3-primers (Table 1) . Reaction mixtures were heated at 949 C for 5 min, followed by 20 cycles of denaturing at 949 C for 30 s, annealing at 639 C for 30 s, and polymerization at 729 C for 30 s, with aˆnal extra 3-min extension. PCR products were ligated into pT7Blue T-vector and used to transform E. coli JM109 cells for DNA sequencing. VH and VL genes were recovered by NheI W NcoI and Bpu1102I W NcoI digestion, respectively, and ligated into the restricted vector pET-27b. Detection of VH and VL fragments in ELISA was done with a mouse anti-HSV mab and a mouse anti-FLAG mab (Sigma, MO, USA), respectively. These expression plasmids (Fig. 2) were each used to transform E. coli BL21(DE3)pLysS strain cells.
Production of recombinant antibody fragments in E. coli. Periplasmic extraction was done as described by Strachan et al. 28) with some modiˆcations. Transformed E. coli BL21(DE3)pLysS cells were grown at 239 C in 250 ml of 2×YT medium containing 25 mg W ml kanamycin and 33 mg W ml chrolamphenicol, and induced by adding isopropyl-b-D-thiogalactopyranoside to the culture medium to aˆnal concentration of 1 mM. After an induction period of 4 h at 239 C, cells were harvested and washed with 250 ml of ice-cold TES buŠer (0.2 M Tris-HCl, 0.5 mM EDTA, 0.5 M sucrose, pH 8.0). After centrifugation, cells were resuspended in 25 ml of ice-cold 5 mM MgSO4. After standing on ice for 30 min, the cells were centrifuged at 10,000 g and 49 C for 10 min. The supernatant was recovered and used for ELISA assay as a scFv antibody.
ELISA with mabs. ELISA assays were done as previously described 26) with some modiˆcations. Wells of microtiter plates (Maxisorp, Nunc, Roskilde, Denmark) were each coated with 100 ml of BPAH-RSA (0.1 mg W ml) in phosphate-buŠered saline (PBS; 10 mM phosphate, 0.9z (w W v) NaCl, pH 7.2) overnight at 49 C, and blocked with 300 ml of Block Ace diluted 1:3 in distilled water. Fifty ml of standards of BPA or BPA-related compounds used in a cross-reactivity test and 50 ml of a mab were added into wells in triplicate, and left for 1 h at 259 C. After washing with PBS, 100 ml of anti-mouse IgG conjugated to HRP diluted in PBS containing 10z Block Ace (PBS-B) was added and incubated for 1 h at 259 C. After washing, 100 ml of chromogenic substrate (100 mg W ml 3,3?,5,5?-tetramethylbenzidine and 0.006z (w W v) H 2 O 2 in 0.1 M acetate buŠer, pH 5.5) was added and incubated for 10 min at 259 C. The enzyme reaction was stopped by adding 100 ml of 1 N sulfuric acid and the A450 was measured in a microplate reader (Corona Electric Co., Ibaraki, Japan).
ELISA with scFv antibodies. An ELISA assay was done as described above except for addition of 50 ml of a scFv antibody in place of a mab, followed by washing and adding 100 ml of anti-HSV mab (0.1 mg W ml) in 2×PBS containing 10z Block Ace reacted for 1 h at 259 C.
ELISA with VH and VL fragments. Wells were coated with 200 ml of BPAH-RSA (0.1 mg W ml) and blocked. A hundred ml of standards of BPA, 50 ml of VL fragment and 50 ml of VH fragment were added and reacted for 1 h at 259 C. After the wells were washed, 200 ml of anti-FLAG mab (1 mg W ml) in PBS-B was added and incubated for 1 h at 259 C. After washing, 200 ml of HRP-labeled anti-mouse IgG antibody in PBS-B was added and incubated for 1 h at 259 C. After washing, 200 ml of chromogenic substrate was added and incubated for 10 min at 259 C. The enzyme reaction was stopped with sulfuric acid, and the A450 was measured.
Noncompetitive ELISA with antisera. The ELISA assay was done as described above in ELISA with mabs except for addition of 50 ml of antiserum in place of a mab.
Results
Preparation of anti-BPA mabs and development of ELISA for BPA
The titer of antisera from mice immunized with BPAH-KLH and BPAH-BSA was tested in noncompetitive ELISA. Mice with a good antibody titer in antisera were used for cell fusion. Culture supernatants of hybridoma cells from fusion experiments were assayed in ELISA and selected hybridoma cells producing anti-BPA antibodies were cloned. Four hybridoma cell lines producing anti-BPA mabs were established. These mabs were named BBA-2187, BBA-2617, BKE-3430, and BTE-3456. The culture supernatant of these cell lines was used as a mab in ELISA without further puriˆcation. Based on the immunoglobulin-isotyping experiments, all of the four anti-BPA mabs were found to have IgG1 heavy chains and k light chains. Thus, these anti-BPA mabs were in the class of IgG.
Assay conditions in ELISA (buŠer pH, reaction temperature, reaction time, dilution rate of mab, and concentration of coating antigen) were examined with the mab BBA-2187, which showed the highest activity among the four mabs towards BPA. The sensitivity of an ELISA assay done at 259 C for BPA in a competitive reaction was similar to that at 379 C, while, the sensitivity of an assay at 49 C was superior to the two former assays (data not shown). However, the reaction temperature in the competitive step was optimized at 259 C since a competition step at 49 C took 2 h and a bit of adverse eŠort due to keeping reagents at 49 C for a longer time. The pH of an assay buŠer was also examined in the range between pH 4 and 9. Except for a decrease of sensitivity at pH 9, the assay sensitivity was not signiˆcantly diŠerent between pH 4 and pH 8 (data not shown). The optimized conditions were described in the materials and methods section.
The standard curves with each of the four mabs for BPA are shown in Fig. 3 . The assays were done at least three times to check su‹cient reproducibility. Data were calculated using at least three sets of assays obtained on diŠerent days. IC50 values were deˆned as the concentration of the compound required to reduce the absorbance of control (zero concentration of analyte) to half. The IC50 values of BBA-2187, BBA-2617, BKE-3430, and BTE-3456 for BPA were 0.59 ng W ml, 1.9 ng W ml, 1.5 ng W ml, and 1.6 ng W ml, respectively. Thus, it was found that the ELISA with BBA-2187 was the most sensitive towards BPA among the four anti-BPA mabs. The detection limit of BPA in the ELISA with BBA-2187 was 0.13 ng W ml as IC20.
cDNA Cloning of VH and VL of four anti-BPA mabs Four hybridoma cell lines producing the anti-BPA mabs BBA-2187, BBA-2617, BKE-3430, and BTE-3456 were used as sources of anti-BPA immunoglobulin genes. Two mg of mRNA extracted from 2×10 7 cells of each hybridoma cell line was used for theˆrst-strand cDNA synthesis. To isolate immunoglobulin cDNAs, the 5?-RACE method was used because DNA sequences of the immunoglobulin constant region are consistent. Then, two GSPs complementary to constant regions of IgG1 and k chains were each designed for the 5?-RACE method. An expected size of cDNA fragments (approximately 750 bp) were ampliˆed with each of GSPs (data not shown). DNA sequencing revealed that all of inserts were murine immunoglobulin genes. The cloned VH cDNA sequences of BBA-2187, BBA-2617, and BTE-3456 contained 357 bp encoding 119 amino acids, and that of BKE-3430 contained 366 bp encoding 122 amino acids. The nucleotide sequences of cDNA clones coding for the VH domains of BBA-2187, BBA-2617, BKE-3430, and BTE-3456 were registered at GenBank and their accession numbers are AB097934, AB097935, AB097936, and AB097937, respectively. Similarly, the cloned VL cDNA sequences of BBA-2187, BBA-2617, BKE-3430, and BTE-3456 contained 333 bp, 336 bp, 339 bp and 336 bp encoding 111 amino acids, 112 amino acids, 113 amino acids and 112 amino acids, respectively. The nucleotide sequences of cDNA clones coding for the VL domains of BBA-2187, BBA-2617, BKE-3430, and BTE-3456 were also registered at GenBank and their accession numbers are AB097938, AB097939, AB097940, and AB097941, respectively.
The amino acid sequences of the variable regions of four mabs were compared. It was found that the heavy chain of BBA-2187, BBA-2617, and BTE-3456 was a member of the family XIX subgroup IB and had a k light chain from family I subgroup II, and the heavy chain of BKE-3430 belonged to the family VIII subgroup IIA and had a k light chain from the family II subgroup I. 29) The alignment of the VH and VL sequences is shown in Fig. 4 . It was found that the amino acid sequences of variable regions of BBA-2187, BBA-2617, and BTE-3456 were very similar to one another, except for BKE-3430. The identity in the amino acid sequence of the VH of BBA-2187 was 98z for BBA-2617, 92z for BTE-3456, and 45z for BKE-3430, and in that of the VL of BBA-2187 was 91z for BBA-2617, 86z for BTE-3456, and 63z for BKE-3430. In general, almost all of the mouse immunoglobulins registered in database have 16 amino acid residues in the framework region (FR) 2. However, the region of VL of BBA-2187 had 15 amino acid residues. Therefore, it was found that BBA-2187 had a unique VL domain.
Anti-BPA recombinant scFv antibodies
The scFv genes were constructed for four anti-BPA mabs by PCR using primers complementary to each 5?-end and 3?-end of the variable regions of four mabs. Each of the primers contained either a speciˆc restriction enzyme site for directional cloning or a synthetic peptide linker sequence. In theˆrst round, VH and VL cDNAs were ampliˆed and about 400 bp of PCR products were obtained. Assembly of both VH and VL cDNA fragments was done in the second PCR. About 750 bp of the resulting products were cloned into pT7Blue T-vector and used to transform E. coli cells. The recombinant plasmids were veriˆed to contain neither nucleotide deletions nor substitutions by DNA sequencing and digested with NheI W NcoI restriction enzymes to clone into pET-27b vector, forming pBBA-2187scFv, pBBA-2617scFv, pBKE-3430scFv, and pBTE-3456scFv. The four expression plasmids constructed were each used to transform E. coli BL21(DE3)pLysS cells. Recombinant E. coli cells were cultured in 2×YT medium containing kanamycin and chloramphenicol, and scFv antibodies were each extracted by the osmotic shock. The periplasmic fractions were each directly tested by ELISA for their ability to bind to free BPA.
Standard curves for BPA with the scFv antibodies are shown in Fig. 5 . The reactivity of scFv antibodies towards BPA was similar to that of the corresponding parent mabs. The IC 50 values with BBA2187scFv, BBA-2617scFv, BKE-3430scFv, and BTE3456scFv were 0.32 ng W ml, 0.81 ng W ml, 0.63 ng W ml and 0.93 ng W ml, respectively. The results showed that the IC50 values with the scFv antibodies were comparable to those with the corresponding parent mabs. The BBA-2187scFv was the most reactive among four anti-BPA scFv antibodies, the same as with the mabs.
Then, BBA-2187scFv was further puriˆed from periplasmic extracts and both crude scFv antibody and puriˆed scFv antibody were used in an ELISA. The puriˆed BBA-2187scFv showed reactivity similar to the crude scFv antibody (data not shown). The assay results indicated that some proteins in the periplasmic extracts did not aŠect the reactivity of BBA-2187scFv antibody towards BPA in ELISA. Therefore, crude BBA-2187scFv was used in ELISA for further studies.
Cross-reactivity
The speciˆcity of BBA-2187 and BBA-2187scFv was tested towards structurally related compounds in ELISA for further characterization. The percent cross-reactivity was calculated as the ratio of the IC50 of BPA to that of a tested compound. The IC50 values and the percent cross-reactivity for BPA-related compounds are listed in Table 2 . Both antibodies reacted slightly with bisphenol E and bisphenol F, 
Discussion
We attempted to develop a highly sensitive ELISA based on mabs for BPA, which has been widely detected at ppb to ppt levels in environmental water samples. The optimized ELISA based on BBA-2187 was the most sensitive among four anti-BPA mabs and the quantitation limit was 0.13 ng W ml for BPA. The ELISA assay established here was as sensitive as those of HPLC-ECD (quantitaion limit; 0.2 ng W ml), 30) HPLC-FLD (detection limit; 0.9 ng W ml), 31) and LC-MS (detection limit; 0.1 ng W ml). 32) Therefore, the ELISA developed in this study seemed to be useful in practice for detection of BPA in environmental water samples at actual low levels. This ELISA was more sensitive than the other ELISAs for BPA reported. [33] [34] [35] [36] The ELISA developed in this study was also more speciˆc to BPA than the other ELISAs reported. For example, the cross-reactivity with bisphenol E was 7.6z in this ELISA, whereas the cross-reactivity with bisphenol E ranged from 18z to 144z in the other ELISAs reported. 33, 34, 36) Recently, the ELISA kit based on BBA-2187 has become commercially available. 37) In order to characterize these mabs further, the anti-BPA scFv antibodies corresponding to the mabs were each produced by the culture of the recombinant E. coli cells. The ELISA based on the anti-BPA scFv antibodies gave the IC50 values for BPA similar to those based on the corresponding mabs. As would be expected, BBA-2187scFv was the most sensitive towards BPA among the four anti-BPA scFv antibodies in ELISA. The alignment of the amino acid sequences in the variable regions of four anti-BPA mabs showed that there was a high degree of sequence identity among the three antibodies, but not BKE-3430. Particularly, it was found that the most sensitive BBA-2187 had a unique VL domain which consisted of 15 amino acid residues in FR2, although the domain generally contains 16 amino acid residues in this region. This unique structural feature of the VL may re‰ect the speciˆc association with the VH, resulted in the highest reactivity to BPA in ELISA.
The ELISA based on the scFv antibodies took more time than that based on the mabs because of the additional reaction step. This problem will be resolved by using the scFv antibodies fused with an enzyme or another marker protein. On the other hand, the production of the scFv antibodies by the culture of the recombinant E. coli cells was even more e‹cient than that of the mabs. Therefore, the scFv antibodies seemed to be reliable for practical application to ELISA and immunoa‹nity columns.
The cross-reactivity of BBA-2187scFv with BPArelated compounds was similar to that of the parent mab BBA-2187. The scFv antibody speciˆc to the insecticide parathion also showed cross-reactivity similar to the parent mab with structurally related compounds in ELISA. 38) Both BBA-2187 and BBA2187scFv slightly cross-reacted with bisphenol E and bisphenol F, both of which have only one (bisphenol E) and two (bisphenol F) of the methylene groups deleted as compared with that of BPA, since the cross-reactivity of both antibodies with bisphenol E was higher than that to bisphenol F. Thus, these methylene chains may be important for the antigenantibody interaction. Also, neither antibody crossreacted with 4-tert-butylphenol, indicating that both antibodies may recognize both hydroxyphenyl groups in BPA. Based on the results of the crossreactivity tested, BBA-2187 was found to recognize speciˆcally the whole molecule of BPA.
It has been known that the VH and VL fragments of an antibody associated each other in the presence of an antigen under certain conditions. 39, 40) When the VH and VL fragments of BBA-2187 were separately prepared and used for ELISA together with coincubation with BPA, both VH and VL fragments seemed to associate noncovalently each other via the antigen BPA in ELISA, although the reactivity was lower than that with BBA-2187scFv. Thus, it was suggested that the VH and VL of BBA-2187 interacted speciˆcally with each other and that the peptide linker of BBA-2187scFv allowed both VH and VL to be more stably maintained. When heterologous combinations of the VH and VL fragments based on BBA-2187 were also examined, the VH fragment of BBA-2187 associated with each of the VL fragments of BBA-2617 and BTE-3456 to react with BPA, although the reactivity of these combinations was lower than the homologous combination. On the other hand, the VL fragment of BBA-2187 assembled speciˆcally with the VH fragment of BBA-2187, but not with the VH fragments of the other anti-BPA antibodies. The results suggested that the conformation of the VL fragment of BBA-2187 may be diŠerent from the others. The FR2 in the VL appeared to be the key factor for the speciˆc assembly between VH and VL of BBA-2187, since the region had a unique sequence as mentioned above. The VH and VL fragments of BKE-3430 did not associate with the VL and VH fragments of BBA-2187, respectively, probably due to relatively low identity of the amino acid sequences in the variable regions between these mabs.
